DR. ELIZABETH A MARTIN MD
Prescription History 1609219021
Ophthalmology in Silverdale, WA
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. ELIZABETH A MARTIN MD, an active Ophthalmology specialist practicing in Silverdale, WA. Our medical registry currently tracks 25 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 3,008 documented patient claims. Among these therapy options, the most frequently utilized medication is Latanoprost, which accounts for 793 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other WA PrescribersVs. WA Avg |
|---|---|---|---|
| Latanoprost | 793 | $22.18▼ below WA avg | ▲ More than typical |
About Latanoprost: Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (such as ocular hypertension). Show more ▾ It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness. A prostaglandin F analog used to treat OCULAR HYPERTENSION in patients with GLAUCOMA. In 2023, this provider wrote 793 Medicare prescriptions for Latanoprost, about 6.6 times the volume of the typical Washington prescriber of this medication (120). Medicare paid an average of $22.18 per fill, versus $24.23 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the WA average for this medication. 1,859.1 30-Day Fills standardized to 30-day supplies 55,118 Days of Medication total across all patients in 2023 | |||
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 494 | $36.87 | ▲ More than typical |
About Dorzolamide-Timolol: This product contains two drugs used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers, and dorzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2023, this provider wrote 494 Medicare prescriptions for Dorzolamide-Timolol, about 7.3 times the volume of the typical Washington prescriber of this medication (68). Medicare paid an average of $36.87 per fill, versus $33.25 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 1,125.8 30-Day Fills standardized to 30-day supplies 33,683 Days of Medication total across all patients in 2023 | |||
| Brimonidine Tartrate | 389 | $27.24▼ below WA avg | ▲ More than typical |
About Brimonidine Tartrate: This medication is used to treat open-angle glaucoma or high fluid pressure in the eye. Show more ▾ Lowering high fluid pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This medication lowers pressure by allowing better fluid drainage from within the eye and also by reducing the amount of fluid formed in the eye. It is known as an alpha agonist. This drug is not recommended for use in children less than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 389 Medicare prescriptions for Brimonidine Tartrate, about 7.2 times the volume of the typical Washington prescriber of this medication (54). Medicare paid an average of $27.24 per fill, versus $34.92 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the WA average for this medication. 926.3 30-Day Fills standardized to 30-day supplies 27,529 Days of Medication total across all patients in 2023 | |||
| Timolol Maleate | 255 | $24.41 | ▲ More than typical |
About Timolol Maleate: This medication is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers. A beta-adrenergic antagonist that is similar in action to PROPRANOLOL; the levo-isomer is more active. Timolol has been proposed as an anti-hypertensive, anti-arrhythmic, anti-angina, and anti-glaucoma agent. It is also used in the treatment of MIGRAINE DISORDERS and tremor. In 2023, this provider wrote 255 Medicare prescriptions for Timolol Maleate, about 4.2 times the volume of the typical Washington prescriber of this medication (61). Medicare paid an average of $24.41 per fill, versus $22.79 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 632.3 30-Day Fills standardized to 30-day supplies 18,707 Days of Medication total across all patients in 2023 | |||
| Dorzolamide Hcl | 170 | $30.70▼ below WA avg | ▲ More than typical |
About Dorzolamide Hcl: Dorzolamide is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. It belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2023, this provider wrote 170 Medicare prescriptions for Dorzolamide Hcl, about 4.4 times the volume of the typical Washington prescriber of this medication (39). Medicare paid an average of $30.70 per fill, versus $31.95 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the WA average for this medication. 387.7 30-Day Fills standardized to 30-day supplies 11,551 Days of Medication total across all patients in 2023 | |||
| Prednisolone Acetate | 140 | $54.67 | ▲ More than typical |
About Prednisolone Acetate: This medication is used to treat certain eye conditions due to inflammation or injury. Show more ▾ Prednisolone works by relieving symptoms such as swelling, redness, and itching. It belongs to a class of drugs known as corticosteroids. In 2023, this provider wrote 140 Medicare prescriptions for Prednisolone Acetate, about 1.5 times the volume of the typical Washington prescriber of this medication (95). Medicare paid an average of $54.67 per fill, versus $48.29 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 263 30-Day Fills standardized to 30-day supplies 7,350 Days of Medication total across all patients in 2023 | |||
| Alphagan PBrimonidine Tartrate | 86 | $550.42 | ▲ More than typical |
About Alphagan P: This medication is used to treat open-angle glaucoma or high fluid pressure in the eye. Show more ▾ Lowering high fluid pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This medication lowers pressure by allowing better fluid drainage from within the eye and also by reducing the amount of fluid formed in the eye. It is known as an alpha agonist. This drug is not recommended for use in children less than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 86 Medicare prescriptions for Alphagan P, about 3.2 times the volume of the typical Washington prescriber of this medication (27). Medicare paid an average of $550.42 per fill, versus $401.95 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 169.4 30-Day Fills standardized to 30-day supplies 4,916 Days of Medication total across all patients in 2023 | |||
| RocklatanNetarsudil Mesylat/Latanoprost | 80 | $722.02 | ▲ More than typical |
About Rocklatan: Netarsudil/latanoprost is used to treat high pressure inside the eye due to certain eye conditions (such as open-angle glaucoma, ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent vision loss or blindness. In 2023, this provider wrote 80 Medicare prescriptions for Rocklatan, about 2.4 times the volume of the typical Washington prescriber of this medication (34). Medicare paid an average of $722.02 per fill, versus $489.99 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 163.8 30-Day Fills standardized to 30-day supplies 4,909 Days of Medication total across all patients in 2023 | |||
| RhopressaNetarsudil Mesylate | 79 | $693.06 | ▲ More than typical |
About Rhopressa: Netarsudil is used to treat high pressure inside the eye due to certain eye conditions (such as open-angle glaucoma, ocular hypertension). Show more ▾ This medication is thought to work by increasing the flow of fluid out of the eye. This helps lower pressure inside the eye. Lowering high pressure inside the eye can help prevent loss of vision or blindness. In 2023, this provider wrote 79 Medicare prescriptions for Rhopressa, about 2 times the volume of the typical Washington prescriber of this medication (40). Medicare paid an average of $693.06 per fill, versus $465.40 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 168 30-Day Fills standardized to 30-day supplies 4,995 Days of Medication total across all patients in 2023 | |||
| LumiganBimatoprost | 79 | $620.12 | ▲ More than typical |
About Lumigan: Bimatoprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure. A cloprostenol-derived amide that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 79 Medicare prescriptions for Lumigan, about 2 times the volume of the typical Washington prescriber of this medication (39). Medicare paid an average of $620.12 per fill, versus $467.57 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 170.6 30-Day Fills standardized to 30-day supplies 5,035 Days of Medication total across all patients in 2023 | |||
| VyzultaLatanoprostene Bunod | 73 | $628.18 | ▲ More than typical |
About Vyzulta: Latanoprostene bunod is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by controlling the flow of fluid within the eye to maintain a normal pressure. In 2023, this provider wrote 73 Medicare prescriptions for Vyzulta, about 2.1 times the volume of the typical Washington prescriber of this medication (34). Medicare paid an average of $628.18 per fill, versus $461.23 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 156.7 30-Day Fills standardized to 30-day supplies 4,660 Days of Medication total across all patients in 2023 | |||
| CombiganBrimonidine Tartrate/Timolol | 52 | $432.25 | ▲ More than typical |
About Combigan: This combination medication is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This product contains brimonidine and timolol. These medications are used together when 1 drug is not controlling the pressure inside the eye. Brimonidine works by allowing better fluid drainage from within the eye and also by decreasing the amount of fluid formed in the eye. It belongs to a class of drugs known as alpha agonists. Timolol is thought to work by decreasing the amount of fluid formed in the eye. Timolol belongs to a class of drugs known as beta blockers. This medication is not recommended for use in children less than 2 years old due to an increased risk of serious side effects. Ask the doctor or pharmacist for more details. A pharmaceutical preparation of brimonidine tartrate and timolol maleate. The combined ADRENERGIC ALPHA2 RECEPTOR AGONIST and ADRENERGIC BETA-ANTAGONIST activity of these drugs reduce INTRAOCULAR PRESSURE in GLAUCOMA patients. In 2023, this provider wrote 52 Medicare prescriptions for Combigan, about 1.9 times the volume of the typical Washington prescriber of this medication (28). Medicare paid an average of $432.25 per fill, versus $372.18 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 99.5 30-Day Fills standardized to 30-day supplies 2,935 Days of Medication total across all patients in 2023 | |||
| Travoprost | 51 | $234.39 | ▲ More than typical |
About Travoprost: Travoprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure. A cloprostenol derivative that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 51 Medicare prescriptions for Travoprost, about 1.8 times the volume of the typical Washington prescriber of this medication (28). Medicare paid an average of $234.39 per fill, versus $208.38 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 101.3 30-Day Fills standardized to 30-day supplies 2,949 Days of Medication total across all patients in 2023 | |||
| Ketorolac Tromethamine | 39 | $41.14 | ▼ Less than typical |
About Ketorolac Tromethamine: This medication is used to temporarily relieve itching eyes caused by seasonal allergies. Show more ▾ It is also used to prevent and treat eye swelling due to a certain type of eye surgery (cataract removal). Ketorolac belongs to a class of drugs known as nonsteroidal anti-inflammatory drugs (NSAIDs). It works by blocking certain natural substances in your body to reduce pain and swelling. A pyrrolizine carboxylic acid derivative structurally related to INDOMETHACIN. It is a non-steroidal anti-inflammatory agent used for analgesia for postoperative pain and inhibits cyclooxygenase activity. In 2023, this provider wrote 39 Medicare prescriptions for Ketorolac Tromethamine, about half the volume of the typical Washington prescriber of this medication (68). Medicare paid an average of $41.14 per fill, versus $28.29 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 58.4 30-Day Fills standardized to 30-day supplies 1,619 Days of Medication total across all patients in 2023 | |||
| Dorzolamide-TimololDorzolamide/Timolol/Pf | 36 | $204.76 | ▼ Less than typical |
About Dorzolamide-Timolol: This product contains two drugs used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers, and dorzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2023, this provider wrote 36 Medicare prescriptions for Dorzolamide-Timolol, about half the volume of the typical Washington prescriber of this medication (68). Medicare paid an average of $204.76 per fill, versus $33.25 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 64 30-Day Fills standardized to 30-day supplies 1,910 Days of Medication total across all patients in 2023 | |||
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 33 | $360.99 | ▲ More than typical |
About Brimonidine Tartrate-Timolol: This combination medication is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This product contains brimonidine and timolol. These medications are used together when 1 drug is not controlling the pressure inside the eye. Brimonidine works by allowing better fluid drainage from within the eye and also by decreasing the amount of fluid formed in the eye. It belongs to a class of drugs known as alpha agonists. Timolol is thought to work by decreasing the amount of fluid formed in the eye. Timolol belongs to a class of drugs known as beta blockers. This medication is not recommended for use in children less than 2 years old due to an increased risk of serious side effects. Ask the doctor or pharmacist for more details. A pharmaceutical preparation of brimonidine tartrate and timolol maleate. The combined ADRENERGIC ALPHA2 RECEPTOR AGONIST and ADRENERGIC BETA-ANTAGONIST activity of these drugs reduce INTRAOCULAR PRESSURE in GLAUCOMA patients. In 2023, this provider wrote 33 Medicare prescriptions for Brimonidine Tartrate-Timolol, about 1.6 times the volume of the typical Washington prescriber of this medication (21). Medicare paid an average of $360.99 per fill, versus $284.34 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 81.2 30-Day Fills standardized to 30-day supplies 2,417 Days of Medication total across all patients in 2023 | |||
| SimbrinzaBrinzolamide/Brimonidine Tart | 32 | $310.93 | ▲ More than typical |
About Simbrinza: This product contains two medications used to treat high pressure in the eye due to glaucoma (open-angle glaucoma-type) or a certain other eye disease (ocular hypertension). Show more ▾ Lowering high pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This product contains brinzolamide and brimonidine. These two medications work together to decrease the amount of fluid within the eye. Brinzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. Brimonidine belongs to a class of drugs known as alpha agonists. This product is not recommended for use in children younger than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. In 2023, this provider wrote 32 Medicare prescriptions for Simbrinza, about 1.3 times the volume of the typical Washington prescriber of this medication (25). Medicare paid an average of $310.93 per fill, versus $277.33 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 50.7 30-Day Fills standardized to 30-day supplies 1,488 Days of Medication total across all patients in 2023 | |||
| ErythromycinErythromycin Base | 23 | $11.15▼ below WA avg | ▼ Less than typical |
About Erythromycin: Erythromycin is used to treat a wide variety of bacterial infections. Show more ▾ It may also be used to prevent certain bacterial infections. Erythromycin is known as a macrolide antibiotic. It works by stopping the growth of bacteria. This antibiotic treats or prevents only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. In 2023, this provider wrote 23 Medicare prescriptions for Erythromycin, about half the volume of the typical Washington prescriber of this medication (46). Medicare paid an average of $11.15 per fill, versus $14.59 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the WA average for this medication. 25 30-Day Fills standardized to 30-day supplies 465 Days of Medication total across all patients in 2023 | |||
| ZioptanTafluprost/Pf | 19 | $433.07 | ≈ Typical |
About Zioptan: Tafluprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure. In 2023, this provider wrote 19 Medicare prescriptions for Zioptan, about 86% of the volume of the typical Washington prescriber of this medication (22). Medicare paid an average of $433.07 per fill, versus $373.01 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 33 30-Day Fills standardized to 30-day supplies 990 Days of Medication total across all patients in 2023 | |||
| Brinzolamide | 18 | $381.86 | ≈ Typical |
About Brinzolamide: Brinzolamide is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. It belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2023, this provider wrote 18 Medicare prescriptions for Brinzolamide, about 78% of the volume of the typical Washington prescriber of this medication (23). Medicare paid an average of $381.86 per fill, versus $351.72 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 37.6 30-Day Fills standardized to 30-day supplies 1,127 Days of Medication total across all patients in 2023 | |||
| TafluprostTafluprost/Pf | 16 | $280.67 | – No State Data |
About Tafluprost: Tafluprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure. In 2023, this provider wrote 16 Medicare prescriptions for Tafluprost. Medicare paid an average of $280.67 per fill. No state comparison is available for this medication. How often this provider prescribes it No state benchmark is available for this medication. What Medicare paid per fill $280.67 Cost per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 24.3 30-Day Fills standardized to 30-day supplies 715 Days of Medication total across all patients in 2023 | |||
| Levobunolol Hcl | 14 | $18.37▼ below WA avg | ≈ Typical |
About Levobunolol Hcl: This medication is used alone or with other medications to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. Levobunolol belongs to a class of drugs known as beta blockers and works by decreasing the amount of fluid production within the eye. In 2023, this provider wrote 14 Medicare prescriptions for Levobunolol Hcl, about the same volume as the typical Washington prescriber of this medication (15). Medicare paid an average of $18.37 per fill, versus $31.59 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the WA average for this medication. 15.5 30-Day Fills standardized to 30-day supplies 380 Days of Medication total across all patients in 2023 | |||
| Acetazolamide | 13 | $138.64 | ▼ Less than typical |
About Acetazolamide: Acetazolamide is used to prevent and reduce the symptoms of altitude sickness. Show more ▾ This medication can decrease headache, tiredness, nausea, dizziness, and shortness of breath that can occur when you climb quickly to high altitudes (generally above 10,000 feet/3,048 meters). It is particularly useful in situations when you cannot make a slow ascent. The best ways to prevent altitude sickness are climbing slowly, stopping for 24 hours during the climb to allow the body to adjust to the new height, and taking it easy the first 1 to 2 days. This medication is also used with other medications to treat high pressure inside the eye due to certain types of glaucoma. Acetazolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. It works by decreasing the production of fluid inside the eye. It is also used to decrease a buildup of body fluids (edema) caused by heart failure or certain medications. Acetazolamide can work less well over time, so it is usually used only for a short period. It has also been used with other medications to treat certain types of seizures (petit mal and unlocalized seizures). One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337) In 2023, this provider wrote 13 Medicare prescriptions for Acetazolamide, about 68% of the volume of the typical Washington prescriber of this medication (19). Medicare paid an average of $138.64 per fill, versus $63.81 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 17 30-Day Fills standardized to 30-day supplies 510 Days of Medication total across all patients in 2023 | |||
| Carteolol Hcl | 12 | $28.80 | ▼ Less than typical |
About Carteolol Hcl: Carteolol is used alone or with other medications to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. Carteolol is a beta blocker. It is thought to work by reducing the amount of fluid made in the eye. In 2023, this provider wrote 12 Medicare prescriptions for Carteolol Hcl, about half the volume of the typical Washington prescriber of this medication (21). Medicare paid an average of $28.80 per fill, versus $24.37 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 27.8 30-Day Fills standardized to 30-day supplies 823 Days of Medication total across all patients in 2023 | |||
| Atropine Sulfate | 12 | $45.17▼ below WA avg | ▼ Less than typical |
About Atropine Sulfate: This medication is used before eye examinations (such as refraction) and to treat certain eye conditions (such as uveitis). Show more ▾ It belongs to a class of drugs known as anticholinergics. Atropine works by widening (dilating) the pupil of the eye. An alkaloid, originally from Atropa belladonna, but found in other plants, mainly SOLANACEAE. Hyoscyamine is the 3(S)-endo isomer of atropine. In 2023, this provider wrote 12 Medicare prescriptions for Atropine Sulfate, about half the volume of the typical Washington prescriber of this medication (22). Medicare paid an average of $45.17 per fill, versus $47.96 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the WA average for this medication. 26.8 30-Day Fills standardized to 30-day supplies 787 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for DR. ELIZABETH A MARTIN MD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Ophthalmology prescribing approach at this Silverdale, WA practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among WA prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
